Knowledge (XXG)

Bifidus factor

Source 📝

75:. These oligosaccharides are considered to be a "Bifidus Factor" because they form highly desired intestinal bacteria; it is for this reason that baby formula contains added oligosaccharides in order to help build a child's immune system. Studies showed that infants, who were bottled fed, lacked intestinal colonization of bifidobacteria. This lack of bacteria made the babies susceptible to other infectious bacteria and ailments. The infants who were breast fed had higher concentration of the bacteria and their vulnerability too infections was significantly lower. Breast milk had high amounts of oligosaccharides. As, a result, oligosaccharides were added to milk formula. This method worked and the colonization of bifidobacteria leveled. This suggested that the oligosaccharides found in human milk were candidates for the bifidus factor. 438: 90:
The bacteria would break down lactic acid and acetic acid. The environment of the intestine would become acidic, preventing the growth of any harmful pathogens. The function of LBN is unknown and it is possible that oligosaccharides with terminals of Galβ1-3GlcNAc are the bifidus factors.
185:
Fanaro, Silvia; Marten, Berit; Bagna, Rossana; Vigi, Vittorio; Fabris, Claudio; Peña-Quintana, Luis; Argüelles, Federico; Scholz-Ahrens, Katharina E; et al. (2009).
418:
Paul György; Robert F. Norris; Catharine S. Rose (1954). Bifidus factor. I. A variant of Lactobacillus bifidus requiring a special growth factor, 48 (1), 193–201.
408:
O'Callaghan, Amy; van Sinderen, Douwe (2016). Bifidobacteria and Their Role as Members of the Human Gut Microbiota. Frontiers in Microbiology, 7,
479: 31:
in either a product or in the intestines of humans and/or animals. Several products have been marketed as bifidogenic factors, such as several
251: 111: 503: 238:. Advances in Experimental Medicine and Biology. Vol. 902. Cham: Springer International Publishing. p. 120. 498: 472: 187:"Galacto-oligosaccharides Are Bifidogenic and Safe at Weaning: A Double-blind Randomized Multicenter Study" 465: 56: 52: 32: 138:"Dosage-Related Bifidogenic Effects of Galacto- and Fructooligosaccharides in Formula-Fed Term Infants" 353: 288: 277:"Novel Putative Galactose Operon Involving Lacto-N-Biose Phosphorylase in Bifidobacterium longum" 257: 216: 167: 87:
sugars. However, the exact structure and mechanism behind the bifidus factor remains unknown.
387: 369: 322: 304: 247: 208: 159: 449: 437: 419: 409: 377: 361: 312: 296: 239: 198: 149: 72: 28: 357: 292: 382: 341: 317: 276: 492: 423: 154: 137: 300: 261: 220: 445: 171: 203: 186: 136:
Moro, G; Minoli, I; Mosca, M; Fanaro, S; Jelinek, J; Stahl, B; Boehm, G (2002).
68: 36: 243: 413: 373: 308: 346:
Proceedings of the Japan Academy. Series B, Physical and Biological Sciences
391: 326: 212: 163: 365: 55:, showed a strong selective stimulation of bifidobacteria so a ‘ 83:
The bifidus factor might be lacto-N-biose I , which is a derivative of
48: 275:
Kitaoka, Motomitsu; Tian, Jiesheng; Nishimoto, Mamoru (June 2005).
94:
Bifidobacteria might suppress infections in infants and children.
84: 236:
Microbiota of the Human Body: Implications in Health and Disease
59:
effect’ was considered the same as a ‘bifidogenic effect.
342:"Structures and application of oligosaccharides in human milk" 27:) is a compound that specifically enhances the growth of 453: 191:
Journal of Pediatric Gastroenterology and Nutrition
142:
Journal of Pediatric Gastroenterology and Nutrition
71:contains unique and highly diverse human milk 473: 8: 480: 466: 47:Originally, fructose-based carbohydrates 381: 316: 202: 153: 103: 281:Applied and Environmental Microbiology 7: 434: 432: 452:. You can help Knowledge (XXG) by 14: 436: 234:Schwiertz, Andreas, ed. (2016). 155:10.1097/00005176-200203000-00014 301:10.1128/AEM.71.6.3158-3162.2005 1: 424:10.1016/0003-9861(54)90323-9 340:KOBATA, Akira (2010-07-21). 204:10.1097/MPG.0b013e31817b6dd2 520: 431: 244:10.1007/978-3-319-31248-4 414:10.3389/fmicb.2016.00925 79:Composition and function 53:fructooligosaccharides 35:and methyl-N-acetyl D- 16:Biochemistry compound 366:10.2183/pjab.86.731 358:2010PJAB...86..731K 293:2005ApEnM..71.3158K 504:Biochemistry stubs 25:bifidogenic factor 499:Bifidobacteriales 461: 460: 253:978-3-319-31246-0 511: 482: 475: 468: 440: 433: 396: 395: 385: 337: 331: 330: 320: 287:(6): 3158–3162. 272: 266: 265: 231: 225: 224: 206: 182: 176: 175: 157: 133: 127: 126: 124: 122: 116:Encyclopedia.com 108: 73:oligosaccharides 519: 518: 514: 513: 512: 510: 509: 508: 489: 488: 487: 486: 429: 405: 400: 399: 339: 338: 334: 274: 273: 269: 254: 233: 232: 228: 184: 183: 179: 135: 134: 130: 120: 118: 110: 109: 105: 100: 81: 65: 45: 39:in human milk. 17: 12: 11: 5: 517: 515: 507: 506: 501: 491: 490: 485: 484: 477: 470: 462: 459: 458: 441: 427: 426: 416: 404: 401: 398: 397: 352:(7): 731–747. 332: 267: 252: 226: 177: 128: 102: 101: 99: 96: 80: 77: 64: 61: 44: 41: 29:bifidobacteria 21:bifidus factor 15: 13: 10: 9: 6: 4: 3: 2: 516: 505: 502: 500: 497: 496: 494: 483: 478: 476: 471: 469: 464: 463: 457: 455: 451: 448:article is a 447: 442: 439: 435: 430: 425: 421: 417: 415: 411: 407: 406: 403:Other sources 402: 393: 389: 384: 379: 375: 371: 367: 363: 359: 355: 351: 347: 343: 336: 333: 328: 324: 319: 314: 310: 306: 302: 298: 294: 290: 286: 282: 278: 271: 268: 263: 259: 255: 249: 245: 241: 237: 230: 227: 222: 218: 214: 210: 205: 200: 196: 192: 188: 181: 178: 173: 169: 165: 161: 156: 151: 147: 143: 139: 132: 129: 117: 113: 112:"Bifidogenic" 107: 104: 97: 95: 92: 88: 86: 78: 76: 74: 70: 62: 60: 58: 54: 50: 42: 40: 38: 34: 30: 26: 22: 454:expanding it 446:biochemistry 443: 428: 349: 345: 335: 284: 280: 270: 235: 229: 194: 190: 180: 148:(3): 291–5. 145: 141: 131: 119:. Retrieved 115: 106: 93: 89: 82: 66: 46: 24: 20: 18: 197:(1): 82–8. 121:18 December 69:breast milk 63:Breast milk 37:glucosamine 493:Categories 98:References 43:Background 33:prebiotics 374:0386-2208 309:0099-2240 57:prebiotic 392:20689231 327:15933016 262:28970333 221:31875747 213:19172129 164:11964956 383:3066539 354:Bibcode 318:1151866 289:Bibcode 172:9704332 390:  380:  372:  325:  315:  307:  260:  250:  219:  211:  170:  162:  67:Human 49:inulin 444:This 258:S2CID 217:S2CID 168:S2CID 85:mucin 450:stub 388:PMID 370:ISSN 323:PMID 305:ISSN 248:ISBN 209:PMID 160:PMID 123:2021 51:and 420:doi 410:doi 378:PMC 362:doi 313:PMC 297:doi 240:doi 199:doi 150:doi 495:: 386:. 376:. 368:. 360:. 350:86 348:. 344:. 321:. 311:. 303:. 295:. 285:71 283:. 279:. 256:. 246:. 215:. 207:. 195:48 193:. 189:. 166:. 158:. 146:34 144:. 140:. 114:. 19:A 481:e 474:t 467:v 456:. 422:: 412:: 394:. 364:: 356:: 329:. 299:: 291:: 264:. 242:: 223:. 201:: 174:. 152:: 125:. 23:(

Index

bifidobacteria
prebiotics
glucosamine
inulin
fructooligosaccharides
prebiotic
breast milk
oligosaccharides
mucin
"Bifidogenic"
"Dosage-Related Bifidogenic Effects of Galacto- and Fructooligosaccharides in Formula-Fed Term Infants"
doi
10.1097/00005176-200203000-00014
PMID
11964956
S2CID
9704332
"Galacto-oligosaccharides Are Bifidogenic and Safe at Weaning: A Double-blind Randomized Multicenter Study"
doi
10.1097/MPG.0b013e31817b6dd2
PMID
19172129
S2CID
31875747
doi
10.1007/978-3-319-31248-4
ISBN
978-3-319-31246-0
S2CID
28970333

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.